North America Food Safety Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the North America food safety testing market size is projected to expand from USD 7.76 billion in 2025 and USD 8.28 billion in 2026 to USD 10.41 billion by 2031, registering a CAGR of 7.51% between 2026 and 2031.

This report is Segmented by Containment Type (Pathogen, Pesticide and Residue, Mycotoxin, GMO, Allergen, Other), Technology (PCR, Immunoassay, Chromatography and Spectrometry, Others), Application (Pet Food and Animal Feed, Food), and Geography (United States, Canada, Mexico, Rest of North America). Market Forecasts are in Value (USD).

North America Food Safety Testing Market Trends and Insights

Increasing Demand For Stringent Food Safety Compliance

Under the FDA's Food Safety Modernization Act, manufacturers are required to integrate routine microbiological and chemical testing into their production processes. This strategy emphasizes preventive controls, hazard-analysis plans, and enhanced traceability for high-risk foods, moving away from the traditional reliance on end-product sampling. Similarly, USDA-FSIS's FY2025 sampling plan intends to collect approximately 88,031 microbiological samples and 12,400 chemical-residue samples. This extensive effort highlights the agency's shift toward data-driven risk assessments and the use of whole-genome sequencing to trace outbreak sources. In Canada, the Safe Food for Canadians Regulations mandate that all licensed food businesses implement preventive-control plans and maintain traceability records. This alignment with U.S. standards aims to streamline processes and facilitate cross-border trade. The FDA's Food Traceability Rule, with a compliance deadline set for July 2028, allows small processors time to enhance their record-keeping systems. However, many early adopters are already utilizing digital traceability to differentiate their brands and secure premium shelf space. In Mexico, COFEPRIS is modernizing its import-export testing protocols to comply with USMCA commitments. This modernization is driving demand for accredited laboratories capable of issuing certificates recognized by both U.S. and Canadian authorities. Additionally, regulatory requirements are influencing standards such as ISO 17025 accreditation for testing laboratories. Retailers are increasingly relying on certifications from GFSI schemes, including SQF and BRC, as benchmarks for supplier approval.

Rising Frequency Of Foodborne Illness Outbreaks

During 2024 and 2025, the Centers for Disease Control and Prevention monitored 17 to 36 multistate foodborne-illness investigations weekly. Listeria monocytogenes and Salmonella were the leading causes of Class I recalls in ready-to-eat meats, dairy, and produce. A 104-case Salmonella outbreak tied to charcuterie products extended from 2023 into 2024, prompting the USDA-FSIS to enhance Salmonella quantification protocols and expand whole-genome sequencing capabilities for faster contamination source identification. The detection of H5N1 avian influenza in U.S. dairy herds in 2024 initiated a federal testing program that collected over 800 raw-milk samples, highlighting how emerging zoonotic threats can rapidly increase testing demands. Retailers are responding by strengthening supplier requirements and enforcing third-party verification of pathogen-control plans, benefiting accredited laboratories equipped for high-throughput PCR and immunoassay workflows. The cross-border nature of contamination events is evident in Canada's E. coli O157:H7 outbreak in romaine lettuce and Mexico's sporadic Cyclospora cases in fresh produce, emphasizing the need for harmonized testing standards and real-time data sharing among North American regulators, including Health Canada. Compliance remains critical, focusing on HACCP principles and routine validation of critical control points through environmental monitoring.

Elevated Costs Of Advanced Food Safety Testing Technologies

High-resolution mass spectrometry systems, required for multi-residue pesticide analysis and PFAS quantification, involve capital investments exceeding USD 500,000. This significant expense discourages small and mid-sized processors from performing in-house testing, driving demand primarily toward third-party laboratories [peer-reviewed research]. Laboratories serving rural or secondary markets face challenges due to recurring costs linked to whole-genome sequencing platforms and bioinformatics infrastructure, including cloud storage, software licenses, and the need for skilled personnel. The transition from presumptive to confirmatory testing, mandated by certain USDA-FSIS protocols, increases both turnaround time and costs. As a result, manufacturers either negotiate volume discounts with accredited laboratories or invest in rapid screening technologies to reduce the number of samples requiring confirmatory analysis. In contrast to the U.S., where economies of scale benefit the laboratory market, Canada's smaller laboratory sector experiences higher per-test costs and longer lead times, particularly for specialized assays like mycotoxin quantification and allergen validation. Mexico's testing infrastructure remains fragmented, with limited accredited facilities for advanced chromatography and molecular diagnostics. This forces exporters to send samples to U.S. laboratories, incurring additional cross-border logistics costs. Large manufacturers with diverse product portfolios can balance the economic trade-off between proactive testing and recall risks, whereas smaller processors often delay testing until compelled by regulatory inspections or customer audits.

Other drivers and restraints analyzed in the detailed report include:

1. Widespread Adoption Of Blockchain For Supply Chain Traceability
2. Heightened Focus On Food Allergen Detection And Prevalence
3. Challenges In Detecting Emerging And Novel Contaminants

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Pathogen testing accounted for 48.21% of 2025 revenue, underpinned by zero-tolerance Salmonella and Listeria mandates in meat, poultry, and ready-to-eat foods. GMO verification is forecast to grow at 8.25% CAGR through 2031, supported by USDA's bioengineered-food disclosure standard and voluntary non-GMO seals sought by upscale retailers. Pesticide and residue testing gains relevance as the EPA tightens maximum-residue limits and states set independent PFAS thresholds for food packaging. Mycotoxin testing remains essential for grain and nut exports targeting EU and Asian standards. Allergen assays received a boost from sesame's inclusion as a major allergen, while other contaminant testing segments, covering heavy metals and microplastics, advance as research builds regulatory momentum.

Historically, per-sample costs for pathogen testing fell as multiplex PCR throughput improved, yet absolute volumes kept rising due to retail-driven finished-product checks. GMO testing benefited from dual demand: mandatory disclosure on labels and voluntary certification for marketing claims. Digital PCR is now preferred for quantifying below-0.9% GMO thresholds required in European export markets, which elevates the service value of labs offering this specialty. Laboratories that integrate isotope-ratio mass spectrometry into authenticity programs capture higher margins as adulteration incidents spur premium audit requirements.

Complete Report Scope:

• By Containment Type
  • Pathogen Testing
  • Pesticide and Residue Testing
  • Mycotoxin Testing
  • GMO Testing
  • Allergen Testing
  • Other Contaminant Testing
• By Technology
  • Polymerase Chain Reaction
  • Immunoassay-based
  • Chromatography and Spectrometry
  • Others
• By Application
  • Pet Food and Animal Feed
  • Food
    • Meat and Poultry
    • Dairy
    • Fruits and Vegetables
    • Processed Food
    • Crops
    • Other Foods
• By Geography
  • United States
  • Canada
  • Mexico
  • Rest of North America

List of Companies Covered in this Report:

1. SGS SA
2. Eurofins Scientific
3. Bureau Veritas
4. Intertek Group PLC
5. ALS Limited
6. NSF International
7. Merieux NutriSciences
8. NEOGEN Corporation
9. TUV SUD
10. AsureQuality
11. Microbac Laboratories
12. 3M Company
13. Bio-Rad Laboratories
14. Agilent Technologies
15. Thermo Fisher Scientific
16. Danaher
17. Charm Sciences
18. IDEXX Laboratories
19. Romer Labs
20. Genetic ID NA

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support